
← JDD Podcast: Ask the Investigator19. Juni · 40 Min.
From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us
From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us
<p>The post <a href="https://jddonline.com/dual-therapy-for-atopic-dermatitis-lebrikizumab-and-jak-inhibitors-used-in-tandem-for-treatment-resistant-cases-2/">From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us</a> appeared first on <a href="https://jddonline.com">JDDonline - Journal of Drugs in Dermatology</a>.</p>